graph EGM comparisons
avelumab alonetitledocetaxeltitleJAVELIN Lung 200 (all population), 2018 NCT02395172 mNSCLC - L2 - all population 396/396JAVELIN Lung 200 (PDL1 >1%), 2018 NCT02395172 mNSCLC - L2 - PDL1 positive 264/265

Pathology:  mNSCLC - L2 - all population;   mNSCLC - L2 - PDL1 positive; 

mNSCLC - L2 - all populationmNSCLC - L2 - PDL1 positive
JAVELIN Lung 200 (all population), 2018JAVELIN Lung 200 (PDL1 >1%), 2018
avelumab alone2T1T1
docetaxel0T0T0